AstraZeneca PLC (AZN)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
12,604.00p
Buy
12,608.00p
208.00p (+1.68%)
Prices updated at 20 Oct 2026, 16:12 BST
| Prices minimum 15 mins delay
Prices in GBX
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| 12,626.00p - 12,386.00p | |
| 15,732.00p - 9,892.00p | |
| 1.95 | |
| 192,312.31m | |
| 24.75 | |
| 150 | |
| 1,451,769 | |
| 5.10 | |
| 2,600,414.37 | |
| 1.40 | |
| 1,550.91m | |
| GB0009895292 | |
| 6.54 | |
| 1.14 |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.